Tweet
AstraZeneca withdraws Covid-19 vaccine citing low demand
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
notice on its website, the European Medicines Agency also announced the withdrawal, which means that Vaxzevria is no longer authorized to be marketed or sold in European Union countries...
?AstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted the drug could cause very rare but life-threatening injuries.
The British-Swedish drugmaker has already withdrawn its EU marketing authorisation for the vaccine, branded Vaxzevria against new variants of the novel coronavirus, the company said.
The application to withdraw the vaccine from the EU was made on 5 March and came into effect on 7 May...
AstraZeneca recently admitted that its vaccine, initially called Covishield, could cause very rare side effects like blood clots and low blood platelet counts, The Telegraph
The British-Swedish drugmaker has already withdrawn its EU marketing authorisation for the vaccine, branded Vaxzevria against new variants of the novel coronavirus, the company said.
The application to withdraw the vaccine from the EU was made on 5 March and came into effect on 7 May...
AstraZeneca recently admitted that its vaccine, initially called Covishield, could cause very rare side effects like blood clots and low blood platelet counts, The Telegraph
